Crescent Biopharma Statistics
NASDAQ: CBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
13.00+0.09 (+0.70%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Crescent Biopharma by the numbers
Crescent Biopharma has a market capitalization of $543.2 million based on 38.90M shares outstanding. With trailing EPS of $-7.29, Crescent Biopharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 7.8% below its 50-day average and 18.9% below its 200-day average.
Average daily trading volume is 361.17K shares, or about $4.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CBIO valuation vs. peer median
| Metric | CBIO | Peer median | Difference |
|---|---|---|---|
| Market cap | $543.21M | $544.88M | -0% |
| Avg. volume | 361.17K | 1.37M | -74% |
Peer median across 8 companies: AVBP, ACRS, CLYM, ANL, BCAX, GERN, ZVRA, ALMS.
Valuation
- Market cap
- $543.21M
- Price / sales (latest FY)
- 50.09
- EPS (TTM)
- $-7.29
- Shares outstanding
- 38.90M
Price and trading
- Previous close
- 12.91
- Open
- 12.55
- Day range
- 12.53 – 13.30
- 52-week range
- 8.72 – 27.41
- 52-week change
- -0.46%
- Beta
- —
- Volume
- 422.37K
- Average volume
- 361.17K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 543.21M
- Forward Pe
- -4.23
- Eps
- -7.29
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 27.41
- Week52 Low
- 8.72
- Avg Volume
- 361.17K
- Shares Outstanding
- 38.90M
- Ma50
- 14.10
- Ma200
- 16.04
- Pct From52w High
- -52.57%
- Pct From52w Low
- 49.08%